pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4763 |
Genomic Coordinates | chr22: 46113566 - 46113657 |
Description | Homo sapiens miR-4763 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4763-5p | |||||||||||||||||||||||||||||||||
Sequence | 19| CGCCUGCCCAGCCCUCCUGCU |39 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TGIF2 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | TGFB induced factor homeobox 2 | ||||||||||||||||||||
Transcript | NM_021809 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TGIF2 | |||||||||||||||||||||
3'UTR of TGIF2 (miRNA target sites are highlighted) |
>TGIF2|NM_021809|3'UTR 1 GCATCTGCCAAGAAGGGTGCTGAAGGCTCCAGCCAGCTGTCCTGGGTTTCCGTTTTGGTTCCCTTTCATACAGAGGGTTT 81 TCTATGGATCACTGCCAAACATTGGGATCATCTCCTCTGTCCAGAGGTCTTCAACAGGAAGATGCCAGCTGGCACCACTG 161 CACTGTGATGGGGGCCCTCTCCTCTGCTGACTCTGCCGTTTCTCCAGGCCTCCGCTCAGTGATGAGACCAAGAGATCGGA 241 GACAAGCATGGTGCTGCTGCTTCTGCTGCTTCTCCAGAAAATCCCTGGGACACCTTTGTTCCAGCCTGGTTTCCTGGGCT 321 GGGCTCAGGAAAGCTGCCAAATTCAGTCCTATGTTGGGTCCAAGCTGCCCCTGTGCTGTTTCTGTCAAGCCAGGTGTGGA 401 CATTCCAAGTTCATATGCGTGAACAAAAGAAAAGAGGAACCCAGTGGATGTAACAGAACCGACTCCAGTTGAATGTTTAG 481 ATTTTTGCTAAACTGTTTTCTTTTTCCCTTTTTTGCTGTGGTTTGCATTCACGGCAGTAGTTAGCCCAGGTGTGGGGAAC 561 GAGAGTGCACTGCATGATAGCGTTCTGGTGAGCTGGGAAGGACCCACCACTGCCACTGAGGATTGTTTTGGAAGAAAGGA 641 ATATTTTTATCTTGGGGACCAGCTAAGTCTCTGCAGTAGTGTGAAATTCCAAATGGTTGTTTTATCATTGGTTTGGTTTA 721 CCAAAAAAAAGGCAGGGAAAAAAAAAAAAAACAACCGTATGAGCGCATTGGCTTGTCTGCCGCAGGCACAGAAGGGTAGA 801 AAGCCACAGCAGGGGGCAGTCCAGCAGACTCTGACTCAACTTTCTAGGCACCTAGCAGAGAAAGATAAGATCAAAAGGTG 881 TTTGGTTTTTCTTTTAATTTTTATTGTAGTTTTTTTGGGTGGGTGGGGGAAGTAAACTAGACTGAAGCGATGGATTTTTT 961 TTTTCTTTTTTTTCTTTAGTGTTTTTCCCTTTGTTCTTGAACACTTTTGCCCTGCAGCCTCAGTTTTGAATTCTTTTAGC 1041 AACTTGGATTAGAGGGGCCCATATGTCAGAAGCTCCCAGCACCTCCTACTTGGGAGAAAAGTGAGCCATCTGCTGGTCAG 1121 GAAGTCCTCCAGAGAGGCAGCTTTTCCCACAATGGTGGCAGGAAACTTTGGGGAAAGCAGGAATGGTGTCCACTGCTGCG 1201 GAGGAACTGCCTTCAGAGAAGGTGGGGCTGGAAAAGGGTTAGAAGCCTCCTAGCTGGGATTGTCTTTGTTTCACCTTTCT 1281 TTAAATTAGAATTACAGAAGCCCCTGCCCAGTGAACAGATAACGATTGGTCTTATGCTCCTCCCTTTCCCCCATTTTTTC 1361 TTTTGCTGTTTTGTTTTTTGTTTTTTGTTTGTTTGTTTGTTTTTTTGAGACAGAGTCATGCTCTGTCACCCGGGCTGGAG 1441 TGCAGTGGTGCGATCTCAGCTCACTGTAACCTCCGCCTCCCGGGTTCAAGCAATTATTTGCCTCAGCCTCCCGAGTAGCT 1521 GGGATTATAGGCACCCGCCACCATGTCTGGCTTTTAGTAGAGACGGGGTTTCACCATCTTGGCCAGGCTGGTCTTGGAAC 1601 TCCTGACCTCGTGAGCCACCACGCCCAGCCTCTTTTGCTGTTTCATTGCTGACAGTGTTCAACAATATGCCCCATCTTTA 1681 TATATCCTAAGAAACACTAATCCTAGGTTATTGCTAGCCAAAATATTTTTGTCCTGAGTAGTGTCACTGGGCCAAAAGAT 1761 AGATCAGGACGACAGCCTTTAGTTTTCCTGAAATCACCAGGTCAGGCACAAGGAGAAAAGGTTCCTGGATACTGACTAAC 1841 TTGGGTGGGTCTAGCCAGGAGAAAGACAGTAACATGTGTTCTGTACTTTCTGGGAAGATCCCTGAAGCCATCACAGAGGC 1921 TCCCCAACTTCTGAGTCGCCCATCTGTTGCTGTGGGAGTGTGAACGGATCGCTGAAGGAGAGGGAGCTTTGCTCTCTCTA 2001 GGTGGGCAAGTTTCCTGGGCTCTCTGTGTTGCCTCCCTCTGGCTTCTTCCTCCCGTGCCCTCTCCCCGTGTGCCCCAGGG 2081 GGATCAGGGATCCTCACCCTCCTGAGGCCCAGTGGGGAAGAATGAACATGGCTTCATCCAGGTTAACTGATGCTGCCATT 2161 TGCCCAGCCTCTTCCATCCCAGCCCTGTCAGTGAGCCCAGGTCTGGTGCAACTGCTGCAGGATGCCTGTAGTAGGGAACT 2241 CTGGAAGTGTATTGGGCTGAGGTGGGATTTTCCCTCCCCACAGTGCACTGAGCAATGGAGGGTGGTGAGGGAGCCATGCT 2321 GCTGAATTCTGGTTGGCATTTCCCCATTATGTAAAATGGGGTGTTGGGTAGGGCAGACTCTGCTTGGGTTTGGTTGTAAG 2401 ATAAACCTGGAGGAGAAGCACAGTTGTCCCATTGAATTATTTGAGCAAAAACTACTGTAAATAACTTTTTTGTCTTTTGT 2481 CAAATAAAATTTTTTTTTGTTTTTTTAAGCAGAAACAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | LCL-BAC |
Disease | MIMAT0019912 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020023. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_021809 | 3UTR | UGAGCGCAUUGGCUUGUCUGCCGCAGGCACAGAAGGGUAGAAAGCCACAGCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1020023 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL-BAC / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000373874.2 | 3UTR | UUGGCUUGUCUGCCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
69 hsa-miR-4763-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT116035 | DEPDC1 | DEP domain containing 1 | 2 | 2 | ||||||||
MIRT347197 | SIN3B | SIN3 transcription regulator family member B | 2 | 2 | ||||||||
MIRT443248 | C9orf170 | chromosome 9 open reading frame 170 | 2 | 2 | ||||||||
MIRT475164 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT495486 | VTI1B | vesicle transport through interaction with t-SNAREs 1B | 2 | 2 | ||||||||
MIRT496755 | TGIF2 | TGFB induced factor homeobox 2 | 2 | 2 | ||||||||
MIRT496863 | C21orf2 | chromosome 21 open reading frame 2 | 2 | 2 | ||||||||
MIRT499264 | NBPF11 | NBPF member 11 | 2 | 2 | ||||||||
MIRT499517 | MAFK | MAF bZIP transcription factor K | 2 | 2 | ||||||||
MIRT512952 | MKI67 | marker of proliferation Ki-67 | 2 | 2 | ||||||||
MIRT514656 | NUP93 | nucleoporin 93 | 2 | 2 | ||||||||
MIRT517986 | SLC16A13 | solute carrier family 16 member 13 | 2 | 2 | ||||||||
MIRT522816 | KLHL9 | kelch like family member 9 | 2 | 4 | ||||||||
MIRT525495 | CD63 | CD63 molecule | 2 | 2 | ||||||||
MIRT528111 | FOXH1 | forkhead box H1 | 2 | 2 | ||||||||
MIRT531683 | MYO3A | myosin IIIA | 2 | 2 | ||||||||
MIRT534806 | RAB37 | RAB37, member RAS oncogene family | 2 | 2 | ||||||||
MIRT573041 | SHMT1 | serine hydroxymethyltransferase 1 | 2 | 2 | ||||||||
MIRT576720 | Wars | tryptophanyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT609727 | MLXIPL | MLX interacting protein like | 2 | 2 | ||||||||
MIRT610843 | FAM180B | family with sequence similarity 180 member B | 2 | 4 | ||||||||
MIRT614735 | STAT5A | signal transducer and activator of transcription 5A | 2 | 2 | ||||||||
MIRT616981 | EPOR | erythropoietin receptor | 2 | 2 | ||||||||
MIRT617265 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | 2 | 2 | ||||||||
MIRT619405 | INTS7 | integrator complex subunit 7 | 2 | 2 | ||||||||
MIRT621832 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT621893 | TAF13 | TATA-box binding protein associated factor 13 | 2 | 2 | ||||||||
MIRT630263 | SMIM14 | small integral membrane protein 14 | 2 | 2 | ||||||||
MIRT634879 | SENP8 | SUMO/sentrin peptidase family member, NEDD8 specific | 2 | 2 | ||||||||
MIRT636863 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 2 | 2 | ||||||||
MIRT637653 | ADAT1 | adenosine deaminase, tRNA specific 1 | 2 | 2 | ||||||||
MIRT637699 | ZNF439 | zinc finger protein 439 | 2 | 2 | ||||||||
MIRT637759 | GATAD1 | GATA zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT638193 | TAOK1 | TAO kinase 1 | 2 | 2 | ||||||||
MIRT638996 | ADO | 2-aminoethanethiol dioxygenase | 2 | 2 | ||||||||
MIRT642221 | RABAC1 | Rab acceptor 1 | 2 | 2 | ||||||||
MIRT643327 | ATCAY | ATCAY, caytaxin | 2 | 4 | ||||||||
MIRT643419 | ERVMER34-1 | endogenous retrovirus group MER34 member 1, envelope | 2 | 2 | ||||||||
MIRT644499 | RNF14 | ring finger protein 14 | 2 | 2 | ||||||||
MIRT644603 | NT5DC3 | 5'-nucleotidase domain containing 3 | 2 | 2 | ||||||||
MIRT644795 | C21orf59 | chromosome 21 open reading frame 59 | 2 | 2 | ||||||||
MIRT648732 | HIST1H2BD | histone cluster 1 H2B family member d | 2 | 2 | ||||||||
MIRT653856 | SHE | Src homology 2 domain containing E | 2 | 2 | ||||||||
MIRT654129 | RPL14 | ribosomal protein L14 | 2 | 4 | ||||||||
MIRT658876 | DSN1 | DSN1 homolog, MIS12 kinetochore complex component | 2 | 2 | ||||||||
MIRT671624 | C20orf144 | chromosome 20 open reading frame 144 | 2 | 4 | ||||||||
MIRT677367 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT677579 | TRIM65 | tripartite motif containing 65 | 2 | 2 | ||||||||
MIRT678220 | MACC1 | MACC1, MET transcriptional regulator | 2 | 2 | ||||||||
MIRT679613 | RRP36 | ribosomal RNA processing 36 | 2 | 2 | ||||||||
MIRT686081 | PNPLA3 | patatin like phospholipase domain containing 3 | 2 | 2 | ||||||||
MIRT691817 | ICA1L | islet cell autoantigen 1 like | 2 | 2 | ||||||||
MIRT693869 | COX19 | COX19, cytochrome c oxidase assembly factor | 2 | 2 | ||||||||
MIRT694544 | BPNT1 | 3'(2'), 5'-bisphosphate nucleotidase 1 | 2 | 2 | ||||||||
MIRT694926 | ANKS4B | ankyrin repeat and sterile alpha motif domain containing 4B | 2 | 2 | ||||||||
MIRT697758 | USP37 | ubiquitin specific peptidase 37 | 2 | 2 | ||||||||
MIRT697891 | UBE2B | ubiquitin conjugating enzyme E2 B | 2 | 2 | ||||||||
MIRT701569 | MYPN | myopalladin | 2 | 2 | ||||||||
MIRT703081 | GPRIN3 | GPRIN family member 3 | 2 | 2 | ||||||||
MIRT708104 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT708320 | NT5C | 5', 3'-nucleotidase, cytosolic | 2 | 2 | ||||||||
MIRT709878 | TRAF1 | TNF receptor associated factor 1 | 2 | 2 | ||||||||
MIRT713545 | GJB1 | gap junction protein beta 1 | 2 | 2 | ||||||||
MIRT716275 | NUP85 | nucleoporin 85 | 2 | 2 | ||||||||
MIRT716621 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT717987 | C9orf171 | cilia and flagella associated protein 77 | 2 | 2 | ||||||||
MIRT718438 | RAB11B | RAB11B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT722544 | AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | 2 | 2 | ||||||||
MIRT724013 | F2RL1 | F2R like trypsin receptor 1 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|